Not Yet RecruitingPhase 4

HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria

Nigeria400 participantsStarted 2026-02-01

Plain-language summary

Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Male commercial minibus drivers who have worked as a driver for at least 6 months
✓. 18 years old or older
✓. Currently and planning on residing in one of the LGAs during the next 12 months
✓. Owning a mobile phone

Exclusion criteria

✕. Known HIV positivity
✕. Not ability to provide informed consent3
✕. No access to a cell phone

What they're measuring

ART or PrEP Initiation

Timeframe: Baseline and follow-up surveys at 6-,12-, 18-, and 24 months

Trial details

NCT IDNCT07000513

SponsorGeorge Washington University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-02-01

Contact for this trial

Donaldson F Conserve, PhD

917-443-6124 dconservejr@email.gwu.edu

View on ClinicalTrials.gov More HIV trials